Diagnostics Inc News Today

Oracle Investment Management Inc. lowered its position in Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Free Report) by 18.3% during the 4th quarter, Holdings Channel reports. The firm owned 111,575 shares of the medical research company’s stock after selling 24,953 shares during the quarter. Accelerate Diagnostics comprises approximately 0.3% of Oracle Investment Management Inc.’s investment portfolio, making […]

/PRNewswire/ -- ACS Diagnostics, Inc. of Irvine CA, with executive offices in Chattanooga TN, has been granted U.S Patent No. 11,980,452. The patent relates to...

ACSD Granted Significant Telemedicine Patent

Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) was the recipient of a significant increase in short interest during the month of May. As of May 15th, there was short interest totalling 387,300 shares, an increase of 19.9% from the April 30th total of 322,900 shares. Currently, 2.8% of the company’s stock are sold short. […]

Accelerate Diagnostics, Inc. (NASDAQ:AXDX – Get Free Report) saw a large growth in short interest during the month of May. As of May 15th, there was short interest totalling 387,300 shares, a growth of 19.9% from the April 30th total of 322,900 shares. Based on an average daily volume of 73,300 shares, the days-to-cover ratio […]

StockNews.com began coverage on shares of Accelerate Diagnostics (NASDAQ:AXDX – Free Report) in a research note released on Wednesday morning. The brokerage issued a hold rating on the medical research company’s stock. A number of other brokerages have also commented on AXDX. William Blair reiterated an outperform rating on shares of Accelerate Diagnostics in a […]

Kansas State University received a $1 million grant from the Foundation for Food & Agricultural Research to study African swine fever virus.

SAN DIEGO — Patients with severe asthma often experience residual mucus plugging even with biologic treatment, according to a presentation at the American Thoracic Society International Conference. However, their disease burden is significantly lower compared with patients who have not been treated with biologics, Parameswaran Krishna Nair, MD, PhD, Frederick E. Hargreave Teva Innovation

Over The Counter Tests Market to reach over USD 43.40 billion by the year 2031 - Exclusive Report by InsightAce Analytic

Co-Diagnostics (NASDAQ:CODX – Get Free Report) and Biotricity (NASDAQ:BTCY – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, institutional ownership, analyst recommendations, profitability, dividends and risk. Institutional and Insider Ownership 15.0% of Co-Diagnostics shares are […]